Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SLAM/CD150, Mouse anti-Human, Clone: 123303, R&D Systems™

Mouse Monoclonal Antibody

Manufacturer:  R&D Systems MAB16421100

 View more versions of this product

Catalog No. MAB16421100


Add to cart
This item is not returnable. View return policy

Description

Description

SLAM/CD150 Monoclonal antibody specifically detects SLAM/CD150 in Human Samples. It is validated for ELISA.
Specifications

Specifications

SLAM/CD150
123303
ELISA
Q13291
CD 150, CD150, CD150IPO-3, CDw150, IPO-3, signaling lymphocytic activation molecule, signaling lymphocytic activation molecule family member 1, SLAMCD150 antigen, SLAMF1
Mouse myeloma cell line NS0-derived recombinant human SLAM/CD150, Ala21-Pro237, Accession # Q13291
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
6504
Reconstitute at 0.5 mg/mL in sterile PBS.
ELISA
Unconjugated
Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Purified
Mouse
IgG1
100 ug
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Monoclonal
Detects human SLAM/CD150 in direct ELISAs.
Human
SDS
Documents
Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit